96918 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used Lectins
PHARMACEUTICAL COMPOSITION, COMPRISING RECOMBINANT STABILIZED GALECTIN 9 PROTEIN, FOR PREVENTION OR TREATMENT OF RHEUMATOID ARTHRITIS AND BONE DISEASE
#2TREFOIL FACTOR 2/INTERFERON alpha2 FUSION PROTEIN AND APPLICATION THEREOF IN PREVENTION AND TREATMENT OF VIRAL INFECTIOUS DISEASES
#3BIFUNCTIONAL PEPTIDE WITH MUCOADHESIVE AND VIRUS BINDING PROPERTIES
#4GALECTIN-1 DELIVERY FOR THERAPEUTIC CONTROL OF INTESTINAL INFLAMMATION
#5Identification of CLEC-1 Ligand and Uses Thereof
#6METHODS FOR PROMOTING T CELLS RESPONSE
#7ENGINEERED CELLS FUNCTIONALIZED WITH IMMUNE CHECKPOINT MOLECULES AND USES THEREOF
#8COMPOSITIONS, DEVICES AND METHODS COMPRISING MICROBE-TARGETING MOLECULES FOR DIAGNOSING AND TREATING INFECTIOUS DISEASE
#9COMPOSITIONS, DEVICES AND METHODS FOR IDENTIFYING, TREATING AND PREVENTING INFECTIOUS DISEASE USING MICROBE-TARGETING MOLECULES
#10CLEC2 FUSION PROTEIN AND USES THEREOF
#11LENTIVIRAL VECTORS ENABLING ROUTING ANTIGENS TO MHC-II PATHWAY AND INDUCING CD4+ AND CD8+ T-CELL RESPONSES IN A HOST
#12Chimeric inhibitor molecules of complement activation
#13COMPOSITIONS, DEVICES AND METHODS FOR DIAGNOSING AND TREATING INFECTIOUS DISEASE
#14Tissue-homing peptide conjugates and methods of use thereof
#15PHARMACEUTICAL COMPOSITION, COMPRISING RECOMBINANT STABILIZED GALECTIN 9 PROTEIN, FOR PREVENTION OR TREATMENT OF RHEUMATOID ARTHRITIS AND BONE DISEASE
#16Method of promoting a t-cell response or treating cancer by administering an antagonist to human c-type lectin-like receptor-1 (CLEC-1)
#17Microbe-binding molecules and uses thereof
#18IgM-MEDIATED RECEPTOR CLUSTERING AND CELL MODULATION
#19METHOD FOR REDUCING THE IMMUNE RESPONSE TO A BIOLOGICALLY ACTIVE PROTEIN
#20GALECTIN-1/ GALECTIN-3 CHIMERAS AND MULTIVALENT PROTEINS
#21ENGINEERED OPSONIN FOR PATHOGEN DETECTION AND TREATMENT
#22Chimeric antigen receptor with a spacer comprising C2-set Ig-like domains
#23Process for the preparation of recombinant lectin protein
#24CRP capture/detection of gram positive bacteria
#25CARTILAGE-HOMING PEPTIDE CONJUGATES AND METHODS OF USE THEREOF
#26Conjugates of islet neogenesis peptides and analogs, and methods thereof
#27Chimeric inhibitor molecules of complement activation
#28SELF-DIVERSIFYING SYSTEMS AND METHODS OF USE THEREOF
#29METHODS AND COMPOSITIONS FOR TREATING GENETICALLY LINKED DISEASES OF THE EYE
#30Engineered opsonin for pathogen detection and treatment
#31METHOD FOR REDUCING THE IMMUNE RESPONSE TO A BIOLOGICALLY ACTIVE PROTEIN
#32Engineered opsonin for pathogen detection and treatment
#33Microbe-binding molecules and uses thereof
#34Modified gal-1 proteins and uses thereof
#35Engineered opsonin for pathogen detection and treatment
#36CRP capture/detection of gram positive bacteria
#37Cartilage-homing peptide conjugates and methods of use thereof
#38Agglutination of gangliosides for treating alzheimer's disease
#39Microbe-binding molecules and uses thereof
#40Method for the affinity purification of recombinant proteins based on the lectin activity of the CRD of a galectin
#41Methods for promoting t cells response by administering an antagonist of human c-type lectin-like receptor 1 (CLEC-1)
#42IgM-mediated receptor clustering and cell modulation
#43Targeted effector proteins and uses thereof
#44Vesicles comprising lectins expressed on the surface and methods of use thereof to deliver an agent to autophagic and apoptotic cells
#45Conjugates of islet neogenesis peptides and analogs, and methods thereof
#46Nucleic acids encoding lectin-like oxidized LDL receptor 1 antibodies
#47Compositions and methods for treating cancers
#48CD27L collectin fusion proteins and encoding nucleic acids
#49Microbe-binding molecules and uses thereof
#50Chimeric antigen receptor targeting human NKG2DL and methods of preparing said receptor and pharmaceutical composition
#51CYP-P22 biocatalytic nanoparticles with cytochrome P450 activity for prodrug activation
#52Methods of treating a subject having heart failure that include detecting levels of galectin-3 and soluble ST2
#53Chimeric inhibitor molecules of complement activation
#54METHOD FOR MEASURING GLYCOPROTEIN, METHOD FOR EXAMINING LIVER DISEASE, REAGENT FOR QUANTITATIVE DETERMINATION OF GLYCOPROTEIN, AND GLYCAN-MARKER GLYCOPROTEIN AS AN INDEX FOR CLINICAL CONDITIONS OF LIVER DISEASE
#55Engineered opsonin for pathogen detection and treatment
#56METHOD FOR REDUCING THE IMMUNE RESPONSE TO A BIOLOGICALLY ACTIVE PROTEIN
#57CONJUGATE AND USE THEREOF
#58BIOFILM INHIBITOR
#59Sialylated fetuin-A as a marker of immunotherapy efficacy
#60Biotinylated and oxidized LDL receptor and advanced glycation end product receptor produced using genetically engineered silkworm
#61Chimeric inhibitor molecules of complement activation
#62Methods of treating cardiovascular disorders with lectin-like oxidized LDL receptor 1 antibodies
#63METHOD FOR REDUCING THE IMMUNE RESPONSE TO A BIOLOGICALLY ACTIVE PROTEIN
#64GITRL-collectin fusion proteins and encoding nucleic acids
#65Lectins and applications for the detection of pathological state markers
#66GALECTIN-9-SECRETING CELL, AND PRODUCTION METHOD AND USE OF THE SAME
#67CRP capture/detection of gram positive bacteria
#68Methods of treating or selecting a treatment for a subject having heart failure that include detecting levels of galectin-3 and soluble ST2
#69COMPOUNDS AND METHODS FOR TREATMENT OR PREVENTION OF A PATHOGEN INFECTION
#70ENGINEERED OPSONIN FOR PATHOGEN DETECTION AND TREATMENT
#71CD40L collectin fusion proteins and encoding nucleic acid molecules
#72Leukolectins and uses thereof
#73Microbial glycans as a target of human intelectin
#74Galectin-3 Inhibitor (Gal-3M) is Associated with Additive Anti-Myeloma and Anti-Solid Tumor Effects, Decreased Osteoclastogenesis and Organ Protection when Used in Combination with Proteasome Inhibitors
#75Galectin-3 Inhibitor (Gal-3M) is Associated with Additive Anti-Myeloma and Anti-Solid Tumor Effects, Decreased Osteoclastogenesis and Organ Protection when Used in Combination with Proteasome Inhibitors
#76Modified galectin-9 protein
#77GALECTIN-3 INHIBITOR (GAL-3M) IS ASSOCIATED WITH ADDITIVE ANTI-MYELOMA AND ANTI-SOLID TUMOR EFFECTS, DECREASED OSTEOCLASTOGENESIS AND ORGAN PROTECTION WHEN USED IN COMBINATION WITH PROTEASOME INHIBITORS
#78Chimeric inhibitor molecules of complement activation
#79FUSION PROTEINS FORMING TRIMERS
#80Trail collectin fusion proteins
#81METHOD FOR REDUCTION OF 1->3 READING FRAME SHIFTS
#82BIOFILM INHIBITOR
#83ON-COLUMN ENZYMATIC CLEAVAGE
#84Lectin-like oxidized LDL receptor 1 antibodies and methods of use
#85Binding-site modified lectins and uses thereof
#86Methods of Detecting Cells with a Disrupted Cell Membrane, Cells Infected with A Pathogen, Dying Cells or Dead Cells
#87METHOD FOR REDUCING THE IMMUNE RESPONSE TO A BIOLOGICALLY ACTIVE PROTEIN
#88Methods of determining efficacy of treatment in a subject having heart failure
#89Fusion proteins forming trimers
#90ANTI-TUMOR AGENT OTX-008 TARGETS HUMAN GALECTIN-1
#91Methods for increasing the embryo implantation rate in mammals
#92NOVEL COLLECTIN
#93Chimeric inhibitor molecules of complement activation
#94Sugar-chain modified yeast and method for producing glycoprotein using the same
#95Collectin
#96Human leukolectins and uses thereof
#97Polypeptide acting to enhance ischemic diseases
#98Engineered opsonin for pathogen detection and treatment
#99Modified galectin 9 proteins and methods of treatment using them
#100Methods predicting risk of an adverse clinical outcome
#101Stabilization of bio-sensors for applications
#102GalNAc-SPECIFIC BINDING MOLECULES AND USES THEREOF
#103Method for measuring glycoprotein, method for examining liver disease, reagent for quantitative determination of glycoprotein, and glycan-marker glycoprotein as an index for clinical conditions of liver disease
#104Galectin-immunoglobulin chimeric molecules
#105Polypeptides that Bind TRAIL-R1 and TRAIL-R2
#106Signature Of Secreted Protein Isoforms Specific To Ovarian Cancer
#107COMBINATORIAL LIBRARIES OF PROTEINS HAVING THE SCAFFOLD STRUCTURE OF C-TYPE LECTIN-LIKE DOMAINS
#108Protein substance having triple helix structure and manufacturing method therefor
#109PEPTIDES DERIVED FROM FICOLIN AS SURFACTANTS
#110Fusion proteins forming trimers
#111Polypeptides that Bind TRAIL-R1 and TRAIL-R2
#112HCL-K1 Polypeptide Which Offers Collectin Activity
#113BINDING-SITE MODIFIED LECTINS AND USES THEREOF
#114Leukolectins and uses thereof
#115Expression and purification of HIP/PAP and uses therefor
#116Induction of flocculation in photosynthetic organisms
#117Modified Galectin-2 and Uses Thereof
#118Methods of Detecting Cells with a Disrupted Cell Membrane, Cells Infected with A Pathogen, Dying Cells or Dead Cells
#119Polypeptides that Bind IL-23R
#120Combinatorial Libraries Based on C-type Lectin-like Domain
#121Novel Collectin
#122HSP70-Based Treatment for Autoimmune Diseases and Cancer
#123Fusion Proteins of Mannose Binding Lectins for Treatment of Disease
#124METHODS FOR PREVENTION AND TREATMENT OF INFECTIONS WITH SUPRAPHYSIOLOGICAL DOSES OF MANNAN-BINDING LECTIN (MBL) AND FICOLIN-MBL FUSION PROTEINS
#125Galectin sequences and compositions and methods utilizing same for treating or diagnosing arthritis and other chronic inflammatory diseases
#126IgM-mediated receptor clustering and cell modulation
#127Peptides and pharmaceutical compositions for treating connective tissue
#128Modified galectin 9 proteins and use thereof
#129Collectin fusion proteins comprising TNF or trail
#130Tick galectin
#131Expression and purification of HIP/PAP and uses therefor
#132Polypeptides that bind Trail-R1 and Trail-R2
#133MULTIMERISED HIV FUSION INHIBITORS
#134Tetranectin Trimerizing Polypeptides
#135GAINAC SPECIFIC BINDING MOLECULES AND USES THEREOF
#136Trimerising module
#137Galectin 9-Polymer Conjugates
#138Composition and Uses of a Galectin for Treatment of Dry Eye Syndrome
#139Trimerising module
#140HCL-K1 Polypeptide Which Offers Collectin Activity
#141Engineered lectin oligomers with antiviral activity
#142Collectin
#143Galectin sequences and compositions and methods utilizing same for treating or diagnosing arthritis and other chronic inflammatory diseases
#144Broad Spectrum Antiviral Compositions
#145TNF antagonists
#146MOLECULE AND CHIMERIC MOLECULES THEREOF
#147Trimeric IL-1Ra
#148Targeting-enhanced activation of galectins
#149COMPOSITIONS AND METHODS FOR REGULATING RECEPTOR CLUSTERING
#150Carbohydrate Ligands Specific For MHC Molecules
#151Method for reducing the immune response to a biologically active protein
#152Regulatory T-Cells Containing Galectins for the Therapy and Diagnosis of Diseases
#153Method comprising nanofiltration to obtain an MBL product safe from infectious agents and the product obtainable by this method
#154Novel Modified Galectin 8 Proteins and Use Thereof
#155ISOLATED LECTIN POLYPEPTIDES CONSISTING OF TRUNCATED MAMMALIAN UDP-GalNAc:POLYPEPTIDE N- ACETYLGALACTOSAMINYLTRANSFERASES
#156Galectin 11
#157PRODUCTION OF HIGH MOLECULAR MASS LECTINS
#158Combinatorial libraries of proteins having the scaffold structure of C-type lectin-like domains
#159Indications of mannan-binding lectin (MBL) in the treatment of immuno-compromised individuals
#160Galectins -1 and -4 in tumor development
#161Compositions and methods of using galectin-8 as an inhibitor of tumor cell growth
#162Trimerising module
#163Galectin 9-inducing factors
#164Tick galectin
#165Novel collectin
#166Carbohydrate-associated proteins
#167Collectin-complement activating protein chimeras
#168Use of lectin library for distinguishing glycoproteins or cells, diagnosing serum or cells, or fractionating glycoproteins or cells
#169Galectin-14 therapeutic molecule and uses thereof
#170Galectin 11
#171Novel galectin sequences and compositions and methods utilizing same for treating or diagnosing arthritis and other chronic inflammatory diseases
#172Multimerised HIV fusion inhibitors
#173Method of analyzing gene expression
#174Mite galectin
#175Sustained release N-terminally truncated galectin-3 and antibodies to galectin-3 carbohydrate ligands for use in treating disease
#176Methods to identify agents modulating functions of polypeptide galnac-transferases, pharmaceutical compositions comprising such agents and the use of such agents for preparing medicaments
#177Tissue-homing peptide conjugates and methods of use thereof